Effects of 4′-chloro-3α-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: Comparison with effects of cocaine

Journal of Pharmacology and Experimental Therapeutics

Volumn 313, Issue 2, 2005, Pages 613-620

  Tanda, Gianluigi ^a,b   Ebbs, Aaron ^a   Newman, Amy H ^a   Katz, Jonathan L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' CHLORO 3ALPHA (DIPHENYLMETHOXY)TROPANE; BENZATROPINE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; 4' CHLORO 3 (DIPHENYLMETHOXY)TROPANE; 4'-CHLORO-3-(DIPHENYLMETHOXY)TROPANE; DRUG DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; LOCOMOTION; MALE; MICRODIALYSIS; NERVE STIMULATION; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; COMPARATIVE STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; LIMBIC SYSTEM; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BENZTROPINE; COCAINE; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIMBIC SYSTEM; MALE; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18044374657     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.080465     Document Type: Article

References (42)

1. Baker LE, Riddle EE, Saunders RB, and Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79.
2. Balster RL and Schuster CR (1973) Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav 20:119-129.
3. Callahan PM, de la Garza R 2nd, and Cunningham KA (1997) Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601-607.
4. David DJ, Zahniser NR, Hoffer BJ, and Gerhardt GA (1998) In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell. Exp Neurol 153:277-286.
5. De La Garza R 2nd, Callahan PM, and Cunningham KA (1998) The discriminative stimulus properties of cocaine: effects of microinfusion of cocaine, a 5-HT1A agonist or antagonist, into the ventral tegmental area. Psychopharmacology 137:1-6.
6. Di Chiara G, Tanda G, Bassareo V, Pontieri F, Acquas E, Fenu S, Cadoni C, and Carboni E (1999) Drug addiction as a disorder of associative learning: role of nucleus accumbens shell/extended amygdala dopamine. Ann NY Acad Sci 877:461-485.
7. Di Chiara G, Tanda GL, Frau R, and Carboni E (1992) Heterologous monoamine reuptake: lack of transmitter specificity of neuron-specific carriers. Neurochem Int 20 (Suppl):231S-235S.
8. Filip M, Thomas ML, and Cunningham KA (2000) Dopamine D5 receptors in nucleus accumbens contribute to the detection of cocaine in rats. J Neurosci 20:RC98.
9. Finney DJ (1964) Statistical Method in Biological Assay, 2nd ed, Hafner, New York.
10. Haber SN and McFarland NR (1999) The concept of the ventral striatum in nonhuman primates. Ann NY Acad Sci 877:33-48.
11. Ikemoto S (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113:939-955.
12. Izenwasser S, Terry P, Heller B, Witkin JM, and Katz JL (1994) Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors. Eur J Pharmacol 263:277-283.
13. Katz JL, Agoston GE, Alling KL, Kline RH, Forster MJ, Woolverton WL, Kopajtic TA, and Newman AH (2001) Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents. Psychopharmacology 154:362-374.
14. Katz JL, Izenwasser S, Kline RH, Allen AC, and Newman AH (1999) Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine. J Pharmacol Exp Ther 288:302-315.
15. Katz JL, Izenwasser S, and Terry P (2000) Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology 148:90-98.
16. Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650-660.
17. Katz JL, Newman AH, and Izenwasser S (1997) Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine. Pharmacol Biochem Behav 57:505-512.
18. Koob GF (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann NY Acad Sci 877:445-460.
19. Kuczenski R, Segal DS, and Aizenstein ML (1991) Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703-2712.
20. Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
21. Moron JA, Brockington A, Wise RA, Rocha BA, and Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389-395.
22. Newman AH, Allen AC, Izenwasser S, and Katz JL (1994) Novel 3 alpha- (diphenylmethoxy)-tropane analogs: potent dopamine uptake inhibitors without cocaine-like behavioral profiles. J Med Chem 37:2258-2261.
23. Newman AH and Kulkarni S (2002) Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic-a focus on analogues of benztropine and rimcazole. Med Res Rev 22:429-464.
24. Paxinos G and Watson C (1987) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney, Australia.
25. Pontieri FE, Tanda G, and Di Chiara G (1995) Intravenous cocaine, morphine and amphetamine preferentially increase extracellular dopamine in the shell as compared with the core of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308.
26. Pontieri FE, Tanda G, Orzi F, and Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (Lond) 382:255-257.
27. Raje S, Cao J, Newman AH, Gao H, and Eddington ND (2003) Evaluation of the blood-brain barrier transport, population pharmacokinetics and brain distribution of benztropine analogs and cocaine using in vitro and in vivo techniques. J Pharmacol Exp Ther 307:801-808.
28. Ritz MC, Cone EJ, and Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46:635-645.
29. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
30. Sellings LH and Clarke PB (2003) Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 23:6295-6303.
31. Snedecor GW and Cochran WG (1967) Statistical Methods, 6th ed, pp 135-171, Iowa State University Press, Ames, Iowa.
32. Tanda G, Ebbs A, Kopajtic TA, and Katz JL (2004) Alteration of the neurochemical effects of cocaine by muscarinic m1 receptor antagonists. Program No. 573.15. 2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. Online.
33. Tanda G, Pontieri FE, and Di Chiara G (1997a) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (Wash DC) 276:2048-2050.
34. Tanda G, Pontieri FE, Frau R, and Di Chiara G (1997b) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085.
35. Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K Jr, and Berger SP (1999) Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. J Pharmacol Exp Ther 289:110-122.
36. van der Zee P, Koger HS, Gooljes J, and Hespe W (1980) Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur J Med Chem 15:363-370.
37. Williams JM and Steketee JD (2004) Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex. J Neurosci Methods 137:161-165.
38. Wood DM and Emmett-Oglesby MW (1989) Mediation in the nucleus accumbens of the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 33:453-457.
39. Woolverton WL, Hecht GS, Agoston GE, Katz JL, and Newman AH (2001) Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys. Psychopharmacology 154:375-382.
40. Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, and Katz JL (2000) 3′- and 4′-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology 147:426-435.
41. Wu Q, Reith ME, Kuhar MJ, Carroll FI, and Garris PA (2001) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J Neurosci 21:6338-6347.
42. Zahm DS (1999) Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann NY Acad Sci 877:113-128.